Alshihab Safaa, Mohamed Ibrahim Mohamed Izham, Abdul Hadi Muhammad, Syed Abdullah, Arabi Abdul Rahman, Al-Qahtani Awad, Al Mujalli Hanan, Rafie Ihsan, Gaith Al-Kuwari Mohamed, Kandy Mujeeb, Al-Zaidan Manal
Clinical Pharmacy and Practice Department, College of Pharmacy, QU Health, Qatar University, Doha, Qatar.
Primary Health Care Corporation, Doha, Qatar.
J Pharm Policy Pract. 2024 Sep 6;17(1):2395529. doi: 10.1080/20523211.2024.2395529. eCollection 2024.
Anticoagulation therapy is crucial for managing various cardiovascular and thrombotic conditions; however, optimal delivery remains challenging in primary care. Pharmacist-led anticoagulation services have emerged as a potential strategy for enhancing patient care and outcomes in such settings. Understanding the perspectives of key stakeholders is critical for successful implementation.
This study aimed to explore the perceptions of key stakeholders involved in the implementation of pharmacist-led anticoagulation clinics in primary care settings.
A cross-sectional study was conducted using structured, pilot-tested questionnaires between August and October 2023. Patients receiving warfarin, pharmacists, and physicians working across various primary healthcare centres were invited to complete an online survey. Each group of stakeholders had individualised questionnaires to assess their perceptions and expectations with regard to developing pharmacist-led anticoagulation clinics in primary care. Descriptive statistics were used to analyze the data.
The response rates for the survey were 29.4% for physicians, 10.4% for patients, and 48.6% for pharmacists. Participants expressed positive perceptions toward pharmacist-led anticoagulation clinics, acknowledging benefits such as improved access to care, enhanced medication management, and increased patient education. The respondents expressed confidence in the expertise and skills of pharmacists in this role. However, healthcare providers strongly agree that pharmacists should receive additional training specific to anticoagulation management. Establishing standardised protocols and fostering interprofessional collaboration were identified as the main facilitators for practical implementation.
Broad support exists for pharmacist-led anticoagulation clinics in primary care, though additional pharmacist training and accountability concerns need to be addressed for successful implementation.
抗凝治疗对于管理各种心血管和血栓形成疾病至关重要;然而,在初级保健中实现最佳治疗仍具有挑战性。由药剂师主导的抗凝服务已成为在此类环境中改善患者护理和治疗结果的一种潜在策略。了解关键利益相关者的观点对于成功实施至关重要。
本研究旨在探讨参与在初级保健环境中实施药剂师主导的抗凝诊所的关键利益相关者的看法。
于2023年8月至10月间使用经过预试验的结构化问卷进行了一项横断面研究。邀请正在接受华法林治疗的患者、药剂师以及在各个初级医疗保健中心工作的医生完成一项在线调查。每组利益相关者都有个性化的问卷,以评估他们对于在初级保健中开展药剂师主导的抗凝诊所的看法和期望。使用描述性统计分析数据。
医生的调查回复率为29.4%,患者为10.4%,药剂师为48.6%。参与者对药剂师主导的抗凝诊所有积极看法,认可诸如改善就医机会、加强药物管理和增加患者教育等益处。受访者对药剂师在这一角色中的专业知识和技能表示有信心。然而,医疗服务提供者强烈认为药剂师应接受抗凝管理方面的额外培训。建立标准化方案和促进跨专业协作被确定为实际实施的主要促进因素。
初级保健中由药剂师主导的抗凝诊所有广泛支持,不过要成功实施,还需要解决药剂师的额外培训和问责问题。